Article · Journal · 2025

Investigation of Aframomum melegueta compounds as ERK5 inhibitor related to breast cancer via molecular docking and dynamic simulation

Paul Olamide Ottu, Olorunfemi Oyewole Babalola, Cecilia Oluwamodupe, Ayodeji Folasade Oluwatobiloba, Idayat Oyinkansola Kehinde, Olufemi Adebisi Akinola and 2 more

In Silico Pharmacology

• Open access · Green
• World top 10%

Read it10.1007/s40203-025-00304-w